+27 21 888 3000
| Contribution to headline earnings | 30 June 2024 R million |
30 June 2023 R million |
|---|---|---|
| Central treasury | ||
| – Finance income | 379 | 650 |
| – Finance costs | (498) | (628) |
| Net corporate income/(costs) | (412) | 205 |
| (531) | 227 | |
Remgro Finance Corporation Proprietary Limited
Remgro Healthcare Holdings Proprietary Limited
Remgro USA Limited – Jersey
Remgro Management Services Limited
V&R Management Services AG – Switzerland
Profile: Responsible for Remgro’s central treasury function as well as management and support services.
Unlisted companies
Finance income amounted to R379 million (2023: R650 million). This decrease is mainly due to a lower average cash balance, resulting from the Mediclinic acquisition during June 2023, the share repurchase programme from June to August 2023 and the redemption of the Standard Bank preference shares during December 2023. Finance costs were lower at R498 million (2023: R628 million) due to the aforementioned redemption. Other net corporate costs amounted to R412 million (2023: net corporate income of R205 million). The comparative year included an after-tax foreign exchange gain of R522 million relating to the Mediclinic acquisition.
